Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

Older adults who limit their sedentary time have lower metabolic syndrome risk, regardless of how active they are or how ...